Pancreatic Cancer Research

ResearcherBeckman Research InstituteActive in the last 2 years

Michaël Kahn

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-1220-4644; OpenAlex author ID A5015303746. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 2

  1. 3D Chromatin Alteration by Disrupting β-Catenin/CBP Interaction Is Enriched with Insulin Signaling in Pancreatic Cancer. Co-author DOI 10.3390/cancers16122202↗
  2. Differentiation Therapy Targeting the β-Catenin/CBP Interaction in Pancreatic Cancer. Last author DOI 10.3390/cancers10040095↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yufan Zhou · 1 shared paper, 2024 · strength 0.22
  2. Victor X. Jin · 1 shared paper, 2024 · strength 0.22
  3. Yuri Genyk · 1 shared paper, 2018 · strength 0.07
  4. Philipp C. Manegold · 1 shared paper, 2018 · strength 0.07
  5. Heinz‐Josef Lenz · 1 shared paper, 2018 · strength 0.07
  6. Stephen Jacob Pandol · 1 shared paper, 2018 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.